PMGC Holdings stock rises as subsidiary NorthStrive Biosciences advances EL-22 engineered probiotic research through an independent flow cytometry study.

PMGC Holdings shares jumped 21.70% after hours after the company disclosed a merger between two wholly owned subsidiaries in an SEC filing.

PMGC Holdings stock rises as subsidiary NorthStrive Biosciences advances EL-22 engineered probiotic research through an independent flow cytometry study.